Latest News
- UCLA study shows inhibition of gene helps overcome resistance to immunotherapy
New study from UCLA scientists helps explain why some people with advanced cancer may not respond to one of the leading immunotherapies, PD-1 blockade, and how a new combination approach may help overcome resistance to the immunotherapy drug.
December 09, 2019 8:00 AM
detail - Cancer researcher receives grant to study how deep learning can improve immunotherapy
Willy Hugo, PhD, has received a $75,000 grant from the Margaret E. Early Medical Research Trust to help understand the underlying mechanism of response to immune checkpoint inhibitors, a type of immunotherapy drug.
December 03, 2019 8:00 AM
detail - Researchers identify protein that governs human blood stem cell self-renewal
UCLA scientists have discovered a link between a protein and the ability of human blood stem cells to self-renew.
November 29, 2019 12:00 PM
detail - Automated technique helps identify cancer cell metabolism inhibitors
UCLA Jonsson Comprehensive Cancer Center researchers have developed a new automated method for testing hundreds of molecules at a time to find out which ones block cancer cells from consuming glucose — the sugars they need to spread and grow.
November 29, 2019 8:00 AM
detail - A pep talk for pancreatic cancer
In this video, meet UCLA Jonsson Comprehensive Cancer Center researchers Drs. Randy Hecht, David Dawson, Zev Wainberg and Timothy Donahue, who are working on new ways to treat this tough disease, and offer new hope for the future because of breakthroughs in research and patient care.
November 26, 2019 8:00 AM
detail - Dozens of UCLA scientists rank among world’s most-cited researchers
Three UCLA researchers have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state’s stem cell agency.
November 21, 2019 9:00 AM
detail - Grant awarded to develop new imaging techniques that target tumor environment
Dr. Jeremie Calais has been awarded $105,000 from the Society of Nuclear Medicine and Molecular Imaging. The two-year grant will help fund a new UCLA-led study that aims to advance the method of locating cancer by detecting tumor stroma.
November 18, 2019 10:00 AM
detail - New screening method identifies inhibitors of cancer cell metabolism
A new screening system leverages redundancy in an important component of a cell to help identify new drugs that specifically and potently block processes that are essential for cancer cell growth.
November 18, 2019 8:00 AM
detail - Three UCLA scientists receive grants totaling more than $18 million
Three UCLA researchers have received awards totaling more than $18 million from the California Institute for Regenerative Medicine, the state’s stem cell agency.
November 01, 2019 8:00 AM
detail - National Cancer Institute awards UCLA prostate cancer program an $8.7 million grant
The prostate cancer program at the UCLA Jonsson Comprehensive Cancer Center and UCLA Health has been awarded an $8.7 million Specialized Program of Research Excellence, or SPORE, grant from the National Cancer Institute.
October 31, 2019 10:00 AM
detail - Mitochondria’s activity in tumors could predict response to lung cancer drug
Researchers at the UCLA Jonsson Comprehensive Cancer Center and David Geffen School of Medicine at UCLA have identified a new biomarker that could indicate how likely someone is to respond to treatment for lung cancer.
October 30, 2019 11:00 AM
detail - Lung cancer patients with depression likely to receive radiotherapy over surgery
Researchers from the UCLA Jonsson Comprehensive Cancer Center and the Dana-Farber Cancer Institute analyzed 515 patients with early stage non-small-cell lung cancer who were age 65 and older.
October 29, 2019 2:30 PM
detail - Two early career researchers honored by Prostate Cancer Foundation
The Prostate Cancer Foundation has honored two UCLA researchers, Dr. Amar Kishan and Dr. Jeremy Shelton, with PCF Young Investigator awards as part of their 2019 class.
October 29, 2019 8:00 AM
detail - Two UCLA doctors named to National Academy of Medicine
Two UCLA professors, Dr. Denise Aberle and Dr. Carol Mangione, have been elected to the National Academy of Medicine, one of the highest honors in health and medicine.
October 21, 2019 9:00 AM
detail - Creatine powers T cells’ fight against cancer
Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, serves as a molecular battery for immune cells by storing and distributing energy to power their fight against cancer, according to new UCLA research.
October 18, 2019 9:00 AM
detail - UCLA opens pioneering CAR T clinical trial aimed at extending the lives of people diagnosed with the most common types of lymphoma and leukemia
The field of immunotherapy has revolutionized the way people with incurable cancers are treated, saving the lives of many people whose disease would have otherwise been seen as a death sentence.
October 16, 2019 8:00 AM
detail - Antibody eradicates leukemia stem cells
UCLA researchers have discovered a way to eliminate the CML stem cells. Their approach uses an antibody to block a protein that the stem cells rely on to grow.
October 15, 2019 10:00 AM
detail - Cancer researcher honored for work advancing immunotherapy
The Cancer Research Institute has awarded Dr. Antoni Ribas, director of the tumor immunology program at the UCLA Jonsson Comprehensive Cancer Center, with the 2019 William B. Coley Award for his distinguished research in basic and tumor immunology.
October 14, 2019 8:00 AM
detail - Expert second opinion improves reliability of melanoma diagnoses
UCLA researchers have found that obtaining a second opinion from pathologists who are board certified or have fellowship training in dermatopathology can help improve the accuracy and reliability of diagnosing melanoma, one of the deadliest and most aggressive forms of skin cancer.
October 11, 2019 8:00 AM
detail - Clues from DNA could help predict growth of prostate cancer
Researchers from the UCLA Jonsson Comprehensive Cancer Center and other institutions in the U.S., Canada, the United Kingdom and Singapore, have identified 1,178 biomarkers in men’s genome that predict how an individual person’s prostate cancer will grow.
October 07, 2019 9:00 AM
detail